Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21
The size and migration of fibroblasts are increased after Trimethylamine N-oxide (TMAO) treatment compared with non-treated fibroblasts in vitro
Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles
Smiles: CC1=NC(NC2=CN(N=C2)C2CCNCC2)=NC2=C1N(C)C(=O)C1=CC3=CC=CC=C3C=C1N2C
Zaltidine appears to be an effective treatment of duodenal ulcer
Bay 11-7085 acts as an anti-inflammatory agent in both the rat carrageenan paw and the rat adjuvant arthritis model
PF-562271 besylate - CAS# 939791-38-5 aminophen metabolite 3-hydroxy-acetaminophen The size and migration ofPF 562271 Besylate, also known as PF 562,271 and PF 271, is an orally bioavailable small molecule and ATP competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities. PF 562271 inhibits the tyrosine kinase FAK, and to a lesser extent, proline rich tyrosine kinase (PYK2), which may inhibit tumor cell migration, proliferation, and survival. Note: PF 562271 benzesulfonate is also called PF 562271
US$ 1602.50
US$ 1249.50